News
All NewsFDA UpdatesPress Releases
Media
All VideosDigital DetailIndependent CornerInsightsInterviewsMEDcastMedical World NewsMicrositesPeer ExchangePerfect ConsultPodcastsPractice PearlsSponsored WebcastStudent VoicesWebinars/Webcasts
Conferences
Conference CoverageConference Listing
Publications
Pharmacy TimesPharmacy Practice in Focus: OncologyPharmacy Practice in Focus: Health SystemsPharmacy CareersAll PublicationsAbout the PublicationsAuthor SubmissionSubmit to Pharmacy Practice in Focus: OncologySubmit to Pharmacy Practice in Focus: Health SystemsBecome a Peer ReviewerSupplements & Featured Publications
More
Events
Upcoming EventsUpcoming Webinars
CE
Resources
Clinical ForumAmerican Pharmacists MonthEducated PatientInformation for the PharmacistInteractive ToolsPartnersPharmacy Times Oncology Pulse Point: Pharmacist InsightsSponsoredWhiteboards

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • Events
  • CE
  • Resources
  • Subscribe
  • 503B Compounding Pharmacy
  • ADHD
  • Allergy
  • Alzheimer Disease
  • Anxiety
  • Asthma
  • Atopic Dermatitis
  • Biosimilars
  • Bipolar Disorder
  • Brain Health
  • Breast Cancer
  • C. difficile
  • COPD
  • COVID-19
  • Cardiovascular Health
  • Cervical Cancer
  • Cholangiocarcinoma
  • Cholesterol
  • Chronic Kidney Disease
  • Chronic Lymphocytic Leukemia
  • Classical Hematology
  • Colorectal Cancer
  • Continuous Glucose Monitoring
  • Cough and Cold
  • Depression
  • Dermatology
  • Diabetes
  • Digestive Health
  • Dry Eye Disease
  • Epilepsy
  • Eye Care
  • Flu
  • Future of Pharmacy
  • Gastrointestinal Cancer
  • Gastrointestinal Health
  • Gout
  • HER2 Breast Cancer
  • HIV
  • Heart Failure
  • Hematology
  • Hepatitis/MASH
  • Immunization
  • Immuno-oncology
  • Immunoglobulins
  • Infectious Disease
  • Lung Cancer
  • Lymphoma
  • Macular Degeneration
  • Mental Health
  • Migraine
  • Movement Disorders
  • Multiple Myeloma
  • Multiple Sclerosis
  • Myelofibrosis
  • Neurology
  • Neutropenia
  • Osteoporosis
  • Ovarian Cancer
  • Pain Management
  • Parkinson Disease
  • Pediatrics
  • Pneumococcal
  • PrEP
  • Prostate Cancer
  • Psoriasis
  • Psoriatic Arthritis
  • Psychedelics
  • Reproductive Health
  • Respiratory Syncytial Virus
  • Rheumatoid Arthritis
  • Schizophrenia
  • Shingles
  • Skin Cancer
  • Sleep
  • Travel Vaccines
  • Veterinary Pharmacy
  • Vitamins and Supplements
  • Weight Management
  • Women's Health
Spotlight -
Community/Retail|
Hospital|
Oncology|
Pharmacy Technician|
Student
Advertisement

Insights

Advancements and Updates in Therapies for CLL

May 29th 2020

Opportunities to Improve Pharmacy Workflow in the Preparation of Levothyroxine

May 5th 2020

Proper Dosing of Anticoagulants in CAD/PAD

April 21st 2020

Management of Chemotherapy-Induced Nausea and Vomiting

December 20th 2019

Implications of Potential Heparin Shortage

December 6th 2019

Pharmacists' Knowledge of In-Home Drug Testing

September 19th 2019

The Cardiovascular Benefits of GLP-1 Agonists

February 28th 2019

Economic Burden of ABSSSI

January 23rd 2019

Patient Selection and Safety with TNF Inhibitors

December 28th 2018

Understanding Axial Spondyloarthritis

December 28th 2018

Biosimilars and Pharmacy Interchangeability

December 11th 2018

Combination Therapies for Treatment of Type 2 Diabetes

March 30th 2018

Concentrated Insulin Therapy in Advanced Type 2 Diabetes

January 22nd 2018

Sequencing of Therapy for Rheumatoid Arthritis

July 6th 2017

Management of Melanoma

February 27th 2017

Chemotherapy Induced Nausea and Vomiting

July 28th 2016

Travel Health

June 15th 2016

Stroke Prevention in Atrial Fibrillation

September 15th 2015

Weight-Loss Interventions for Obesity

July 27th 2015

Anticoagulant and Antiplatelet Therapies

July 14th 2015

Value-Based Payment Models

July 14th 2015
  • Prev
  • 1
  • 2
  • Prev

Advertisement
Advertisement

Trending on Pharmacy Times

1

Therapeutic Cancer Vaccines: Are We There Yet?

2

In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential

3

FDA Approves Gazyva for Active Lupus Nephritis

4

Amivantamab Shows 45% Response Rate in Pretreated Head and Neck Cancer: OrigAMI-4 Findings

5

EV-303 Trial Shows Unprecedented Survival Benefit With Enfortumab Vedotin Plus Pembrolizumab in Cisplatin-Ineligible Bladder Cancer

  • About Us
  • Clinical Forums
  • Advertise
  • Contact Us
  • Editorial Staff
  • Privacy Policy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Contemporary Clinic
  • OTC Guide
  • Pharmacy Times
  • Pharmacist Mom's Group
  • Pharmacist Mom's Group
Pharmacy Times
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us